What is Global Psoriatic Arthritis Therapeutics Drug Market?
The Global Psoriatic Arthritis Therapeutics Drug Market is a specialized segment of the pharmaceutical industry that focuses on the development and distribution of drugs specifically designed to treat psoriatic arthritis. This condition is a type of inflammatory arthritis that affects some people who have psoriasis, a skin condition characterized by red patches of skin topped with silvery scales. The market encompasses a wide range of therapeutics, including both established and emerging treatments. The global market is driven by the increasing prevalence of psoriatic arthritis and the ongoing research and development activities aimed at finding effective and long-term treatment options. The market is also influenced by factors such as the availability of drugs, the cost of treatment, and the level of awareness about the condition among patients and healthcare providers.
NF Inhibitors, Interleukin Inhibitors, PDE4 Inhibitors, Others in the Global Psoriatic Arthritis Therapeutics Drug Market:
The Global Psoriatic Arthritis Therapeutics Drug Market includes various types of drugs such as NF inhibitors, Interleukin inhibitors, PDE4 inhibitors, and others. NF inhibitors are drugs that inhibit the activity of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB), a protein complex that controls the transcription of DNA and plays a key role in regulating the immune response to infection. Interleukin inhibitors are drugs that block the action of interleukins, which are a group of cytokines that play an important role in the immune system. PDE4 inhibitors are drugs that inhibit the activity of phosphodiesterase 4 (PDE4), an enzyme involved in inflammatory responses. Other types of drugs used in the treatment of psoriatic arthritis include corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), and disease-modifying antirheumatic drugs (DMARDs). Each of these drugs has its own mechanism of action, side effects, and efficacy profile, and the choice of treatment depends on the individual patient's condition and response to therapy.
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies in the Global Psoriatic Arthritis Therapeutics Drug Market:
The Global Psoriatic Arthritis Therapeutics Drug Market caters to various distribution channels including hospital pharmacies, retail pharmacies, and online pharmacies. Hospital pharmacies are typically the first point of contact for patients diagnosed with psoriatic arthritis, as these facilities have the necessary infrastructure and expertise to administer and monitor the use of these drugs. Retail pharmacies play a crucial role in providing access to these therapeutics for patients who are managing their condition at home. Online pharmacies have emerged as a convenient alternative for patients who prefer to have their medications delivered to their doorstep. Each of these distribution channels has its own set of advantages and challenges, and their relative importance in the market can vary depending on factors such as the healthcare infrastructure, regulatory environment, and patient preferences in different regions.
Global Psoriatic Arthritis Therapeutics Drug Market Outlook:
Looking at the market outlook, the global pharmaceutical market is projected to reach a value of 1475 billion USD in 2022, representing a compound annual growth rate (CAGR) of 5% over the next six years. This growth is driven by various factors including the increasing prevalence of chronic diseases, advancements in drug discovery and development, and the growing demand for effective and safe medications. In contrast, the chemical drug market is expected to grow from 1005 billion USD in 2018 to 1094 billion USD in 2022. This market includes drugs that are synthesized using chemical processes and are used to treat a wide range of conditions. The growth of this market is influenced by factors such as the increasing demand for generic drugs, the development of novel chemical entities, and the expansion of the pharmaceutical industry in emerging markets.
| Report Metric | Details |
| Report Name | Psoriatic Arthritis Therapeutics Drug Market |
| CAGR | 5% |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | AbbVie, Janssen Biotech, Novartis, Amgen, CELGENE CORPORATION, Pfizer, Eli Lilly, UCB, Biogen, Bristol-Myers Squibb |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
